IPXL
Impax Laboratories, Inc.
IPXL
IPXL
Delisted
IPXL was delisted on the 4th of May, 2018.
197 hedge funds and large institutions have $3.05B invested in Impax Laboratories, Inc. in 2015 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 64 increasing their positions, 80 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
197
Holders Change
+19
Holders Change %
+10.67%
% of All Funds
5.25%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
40
Increased
64
Reduced
80
Closed
17
Calls
$12.9M
Puts
$4.72M
Net Calls
+$8.14M
Net Calls Change
+$5.48M
Top Buyers
| 1 |
PCM
Pennant Capital Management
Summit,
New Jersey
|
$94.9M |
| 2 |
Franklin Resources
San Mateo,
California
|
$157M |
| 3 |
Neuberger Berman Group
New York
|
$38.4M |
| 4 |
HP
Hound Partners
New York
|
$33.6M |
| 5 |
AG
Aravt Global
New York
|
$125M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$87.8M |
| 2 |
Jennison Associates
New York
|
$31.6M |
| 3 |
SPC
Slate Path Capital
New York
|
$90.7M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
$57.2M |
| 5 |
TA
Teachers Advisors
New York
|
$11.5M |
